TP53 and endometrial cancer: A recent study suggested that the absence of TP53 in endometrial cells initiates chronic inflammation, and a TP53 mutant in endometrial cancer cells induces normal macrophages to express genes that are involved in the inflammatory reaction through signal pathways [26].